|
| |
 |
American Journal of Drug Discovery and Development |
| |
|
Publisher: Academic Journals Inc., USA |
| |
|
|
| |
American Journal of Drug Discovery and Development is an international peer-reviewed scientific journal dedicated to publish rapid scientific developments in drug discovery and associated technologies.
Scope of the journal covers: Novel therapeutic strategies, high-throughput screening, therapeutic targets, combinatorial chemistry, parallel synthesis and library design, drug delivery, ADME/Tox, advances in key compound classes and therapeutic areas, genomics and proteomics, automation and technology, virtual chemistry, informatics, business strategy, clinical trials and other aspects of drug discovery.
|
| |
|
| |
Editor-in-Chief:
Subas Chandra Dinda
|
|
eISSN:
2150-4296
pISSN: 2150-427x |
|
|
|
| |
Volume 2, Number 4, 2012 |
| |
|
| |
Selective Constraint: A Hallmark of Genes Successfully Targeted for Pharmaceutical Development |
|
Qing Zhang,
Ada Solidar,
Nicholas J. Murgolo,
Wynand Alkema,
Wei Ding,
Peter M. Groenen,
Jonathan R. Greene,
Eric L. Gustafson,
Jan Klomp,
Ellie D. Norris,
Ping Qiu
and Gerald J. Wyckoff
|
| American Journal of Drug Discovery and Development Volume 2, Number 4, 184-193, 2012 |
|
Abstract
PDF
Fulltext
Citations
XML
References
|
|
| |
|
| |
|
| |
|
|
|
| |
 |
Navigation |
| |
|
|
| |
|
Indexed In |
| |
|
|
